Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,855 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer.
Chae YK, Othus M, Patel SP, Wilkinson KJ, Whitman-Purves EM, Lea J, Schallenkamp JM, Adra N, Appleman LJ, Alden M, Thomes Pepin J, Ellerton JA, Poklepovic A, Walter A, Rampurwala MM, Robinson WR, Kim HS, Chung LI, McLeod CM, Lopez G, Chen HX, Sharon E, Streicher H, Ryan CW, Blanke CD, Kurzrock R. Chae YK, et al. Among authors: lopez g. Clin Cancer Res. 2024 Dec 16;30(24):5593-5600. doi: 10.1158/1078-0432.CCR-24-0606. Clin Cancer Res. 2024. PMID: 39417692 Clinical Trial.
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia.
Patel SP, Othus M, Chae YK, Dennis MJ, Gordon S, Mutch D, Samlowski W, Robinson WRR, Sharon E, Ryan C, Lopez G, Plets M, Blanke C, Kurzrock R. Patel SP, et al. Among authors: lopez g. Clin Cancer Res. 2024 Jan 5;30(1):33-38. doi: 10.1158/1078-0432.CCR-23-2293. Clin Cancer Res. 2024. PMID: 37882676 Free PMC article. Clinical Trial.
Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort.
Patel SP, Othus M, Chae YK, Huynh T, Tan B, Kuzel T, McLeod C, Lopez G, Chen HX, Sharon E, Streicher H, Ryan CW, Blanke C, Kurzrock R. Patel SP, et al. Among authors: lopez g. J Immunother Cancer. 2024 Jul 27;12(7):e009074. doi: 10.1136/jitc-2024-009074. J Immunother Cancer. 2024. PMID: 39067873 Free PMC article. Clinical Trial.
Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma).
Chae YK, Othus M, Patel SP, Gerber DE, Tanvetyanon T, Kim HS, Chung LI, McLeod CM, Lopez G, Chen HX, Sharon E, Streicher H, Ryan CW, Blanke CD, Kurzrock R. Chae YK, et al. Among authors: lopez g. Ther Adv Med Oncol. 2024 Nov 22;16:17588359241293401. doi: 10.1177/17588359241293401. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39583952 Free PMC article.
A Promotor-Led Pilot Study to Increase Colorectal Cancer Screening in Latinos: The Juntos Contra El Cáncer Program.
Arredondo EM, Dumbauld J, Milla M, Madanat H, Coronado GD, Haughton J, Garcia-Bigley F, Ramers C, Nodora J, Bharti B, Lopez G, Diaz M, Marquez J, Gupta S. Arredondo EM, et al. Among authors: lopez g. Health Promot Pract. 2021 Jul;22(4):491-501. doi: 10.1177/1524839920912240. Epub 2020 Mar 22. Health Promot Pract. 2021. PMID: 32202155 Free PMC article.
Evaluation of a nanostructured CpG-ODN/ascorbyl palmitate as a safe and effective adjuvant for anticrotalic PLA2 serum.
Fusco LS, Lopez GL, Maslovski F, Brignone S, Chaves MG, Calvete JJ, Franco YG, Hernandez D, Van de Velde A, Marin C, Palma S, Maletto B, Moron G, Leiva LC. Fusco LS, et al. Among authors: lopez gl. Trans R Soc Trop Med Hyg. 2025 Jan 3:trae129. doi: 10.1093/trstmh/trae129. Online ahead of print. Trans R Soc Trop Med Hyg. 2025. PMID: 39749533
How Dopamine Enables Learning from Aversion.
Lopez GC, Lerner TN. Lopez GC, et al. Curr Opin Behav Sci. 2025 Feb;61:101476. doi: 10.1016/j.cobeha.2024.101476. Epub 2024 Dec 21. Curr Opin Behav Sci. 2025. PMID: 39719969
Comparing Patient-Reported Outcomes in Patients Undergoing Lumbar Fusion for Degenerative Spondylolisthesis With Predominant Back Pain Versus Predominant Leg Pain Symptoms.
Kaul A, Wolf JC, Anwar FN, Roca AM, Khosla I, Loya AC, Medakkar SS, Jacob KC, Patel MR, Pawlowski H, Parsons AW, Vanjani NN, Prabhu MC, Federico VP, Sayari AJ, Lopez GD, Singh K. Kaul A, et al. Among authors: lopez gd. Clin Spine Surg. 2024 Dec 23. doi: 10.1097/BSD.0000000000001705. Online ahead of print. Clin Spine Surg. 2024. PMID: 39714027
1,855 results